Literature DB >> 34173795

Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review.

Rossella Colantuono1, Elisa D'Acunto1, Daniela Melis1, Pietro Vajro1, Hudson H Freeze2, Claudia Mandato3.   

Abstract

ABSTRACT: An ever-increasing number of disturbances in glycosylation have been described to underlie certain unexplained liver diseases presenting either almost isolated or in a multi-organ context. We aimed to update previous literature screenings which had identified up to 23 forms of congenital disorders of glycosylation (CDG) with associated liver disease. We conducted a comprehensive literature search of three scientific electronic databases looking at articles published during the last 20 years (January 2000-October 2020). Eligible studies were case reports/series reporting liver involvement in CDG patients. Our systematic review led us to point out 41 forms of CDG where the liver is primarily affected (n = 7) or variably involved in a multisystem disease with mandatory neurological abnormalities (n = 34). Herein we summarize individual clinical and laboratory presentation characteristics of these 41 CDG and outline their main presentation and diagnostic cornerstones with the aid of two synoptic tables. Dietary supplementation strategies have hitherto been investigated only in seven of these CDG types with liver disease, with a wide range of results. In conclusion, the systematic review recognized a liver involvement in a somewhat larger number of CDG variants corresponding to about 30% of the total of CDG so far reported, and it is likely that the number may increase further. This information could assist in an earlier correct diagnosis and a possibly proper management of these disorders.
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Entities:  

Mesh:

Year:  2021        PMID: 34173795      PMCID: PMC9255677          DOI: 10.1097/MPG.0000000000003209

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   3.288


  146 in total

1.  Clinical utility gene card for: ALG1 defective congenital disorder of glycosylation.

Authors:  Jaak Jaeken; Dirk Lefeber; Gert Matthijs
Journal:  Eur J Hum Genet       Date:  2015-02-04       Impact factor: 4.246

2.  Compound heterozygous variants of the COG6 gene in a Chinese patient with deficiency of subunit 6 of the conserved oligomeric Golgi complex (COG6-CDG).

Authors:  Guoqiang Li; Yufei Xu; Xuyun Hu; Niu Li; Ruen Yao; Tingting Yu; Xiumin Wang; Weiwei Guo; Jian Wang
Journal:  Eur J Med Genet       Date:  2018-04-28       Impact factor: 2.708

3.  The first case of antenatal presentation in COG8-congenital disorder of glycosylation with a novel splice site mutation and an extended phenotype.

Authors:  Veronica Arora; Ratna Dua Puri; Pratibha Bhai; Nidhish Sharma; Sunita Bijarnia-Mahay; Nandita Dimri; Ashok Baijal; Renu Saxena; Ishwar Verma
Journal:  Am J Med Genet A       Date:  2019-01-28       Impact factor: 2.802

4.  Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation.

Authors:  H Kodera; N Ando; I Yuasa; Y Wada; Y Tsurusaki; M Nakashima; N Miyake; S Saitoh; N Matsumoto; H Saitsu
Journal:  Clin Genet       Date:  2014-05-24       Impact factor: 4.438

5.  Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.

Authors:  Paola Bianchi; Elisa Fermo; Cristina Vercellati; Carla Boschetti; Wilma Barcellini; Alessandra Iurlo; Anna Paola Marcello; Pier Giorgio Righetti; Alberto Zanella
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

6.  Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient.

Authors:  Tommaso Lo Barco; Elisa Osanni; Andrea Bordugo; Giulia Rodella; Maria Iascone; Romano Tenconi; Rita Barone; Bernardo Dalla Bernardina; Gaetano Cantalupo
Journal:  Am J Med Genet A       Date:  2020-10-15       Impact factor: 2.802

7.  Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation.

Authors:  Pietro Vajro; Katarzyna Zielinska; Bobby G Ng; Marco Maccarana; Per Bengtson; Marco Poeta; Claudia Mandato; Elisa D'Acunto; Hudson H Freeze; Erik A Eklund
Journal:  Orphanet J Rare Dis       Date:  2018-01-10       Impact factor: 4.123

8.  ALG11-CDG: Three novel mutations and further characterization of the phenotype.

Authors:  L Regal; P M van Hasselt; F Foulquier; I Cuppen; Hcmt Prinsen; K Jansen; L Keldermans; L De Meirleir; G Matthijs; J Jaeken
Journal:  Mol Genet Metab Rep       Date:  2014-11-25

9.  GANAB and PKD1 Variations in a 12 Years Old Female Patient With Early Onset of Autosomal Dominant Polycystic Kidney Disease.

Authors:  Elizabeth Waldrop; Mohammed A I Al-Obaide; Tetyana L Vasylyeva
Journal:  Front Genet       Date:  2019-02-07       Impact factor: 4.599

10.  Pediatric Liver Disease Patients and Secondary Glycosylation Abnormalities.

Authors:  Anna Bogdańska; Patryk Lipiński; Paulina Szymańska-Rożek; Irena Jankowska; Piotr Socha; Anna Tylki-Szymańska
Journal:  Front Pediatr       Date:  2021-01-13       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.